Skip to main content

Table 5 Summary of subgroups in the diagnosis categories

From: Cerebrospinal fluid pleocytosis level as a diagnostic predictor? A cross-sectional study

  Number Percent Mean CSF leukocytes/μl
CNS infection 106 40.5 1135.5
Meningitis. viral/unknown agent 38 35.9 617.0
Meningitis. acute bacterial 21 19.8 3591.3
Meningitis. borrelia/syphilis 25 23.6 150.6
Encephalitis. infectious 11 10.4 295.3
CNS abscess 3 2.8 4654.3
Other CNS infection
(Including: Herpes zoster with other complication in CNS, Hydrocephalus caused by infectious or parasitic disease classified elsewhere, Meningoencephalitis due to toxoplasmosis, Polyneuropathy caused by infectious or parasitic disease classified elsewhere, Viral infection of CNS unspecified)
8 7.6 66.0
Infection outside CNS 20 7.6 25.0
Endocarditis 2 9.5 113.5
Sepsis 10 47.6 18.8
Other infection with foci outside CNS
(including: Acute pharyngitis, Acute sinusitis, Analabsces, Other pneumonia due to other unspecified microorganism, Oral candidiasis, HIV with other infectious and parasitic disease, Erysiphelas, unspecified, Viralinfection, unspecified, Pilonidal cyst with abscess)
8 40.0 10.6
Non-infectious neurological diseases 79 30.2 63.2
Encephalitis/myelitis. Non-infectious 12 15.2 108.3
Seizures/epilepsy/status epilepticus 6 7.6 15.8
Ischemia/infarction/stroke 11 13.9 38.9
Intracranial haemorrhage 2 2.5 85.0
Multiple sclerosis 15 19.0 15.0
Demyelinating disease/polyneuropathy 5 6.3 10.8
Paralysis/palsy of cranial nerve 3 3.8 29.7
Headache/migraine 5 6.3 10.2
Other neurological
(including: Acute transverse myelitis in demyelinating disease of central nervous system, Other extrapyramidal and movement disorders, Ventriculitis of the brain, unspecified, Sequelae of inflammatory diseases of central nervous system), Obstructive hydrocephalus, Spinal stenosis, Herniation of lumbar disc with radiculopathy, Disorder of central nervous system, unspecified, Symptom of central nervous system unspecified)
20 25.3 129.1
Malignancy. all foci 23 8.8 119.7
Lymphoma 9 39.13 20.7
Leukaemia 3 13.04 16.3
CNS cancer 5 21.74 30.6
Cancer. foci elsewhere
(Including: Malignant neoplasm of unspecified part of unspecified bronchus or lung, Malignant neoplasm of oropharynx, unspecified, Agranulocytosis secondary to cancer chemotherapy)
4 17.39 500.5
Carcinomatosis 2 8.7 181.0
Other 34 13.0 26.2
Sarcoidosis 4 11.4 54.5
Rheumatologic 2 5.7 89.0
Cardiologic. non-infectious 2 5.7 8.0
Observation for suspected/other or not specified findings 8 22.9 25.9
Others
(Including: Acute respiratory failure, Fever, unspecified, Hypokalemia, Complications following infusion, transfusion and therapeutic injection, Care involving use of rehabilitation procedure, unspecified, Unspecified multiple injuries, Hypopituitarism, Benign paroxysmal vertigo)
18 52.9 15.1